JSC Grindeks
Records under this name other than the patents JSC Grindeks holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 5 of 5 · Back to JSC Grindeks
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,940,793 | 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease Lapsed on the fee record Ended Jan 27, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jan 27, 2023 | From the USPTO record |
| US 8,791,273 | 4R,5S-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity Formerly held Lapsed on the fee record Ended Jul 29, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 29, 2022 | From the USPTO record |
| US 8,492,413 | Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer Lapsed on the fee record Ended Jul 23, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jul 23, 2017 | From the USPTO record |
| US 8,153,842 | Method for producing 3-(2,2,2-trimethyl-hydrazinium) propionate dihydrate Lapsed on the fee record Ended Apr 10, 2016 · From the USPTO record | Lapsed on the fee record | Ended Apr 10, 2016 | From the USPTO record |
| US 8,119,835 | Method for preparation of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid Lapsed on the fee record Ended Feb 21, 2016 · From the USPTO record | Lapsed on the fee record | Ended Feb 21, 2016 | From the USPTO record |